Section 721.3440 - Haloalkyl substituted cyclic ethers(a)Chemical substance and significant new uses subject to reporting.(1) The chemical substances haloalkyl substituted cyclic ethers (PMN P-85-368 and P-85-369) are subject to reporting under this section for the significant new uses described in this paragraph.(i) The significant new uses are:(A)Protection in the workplace. Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii) and (a)(6)(v) and (a)(6)(vi), (b) [concentration set at 1.0 percent], and (c).(B)Hazard communication program. Requirements as specified in § 721.72 (a), (d), (e) [concentration set at 1.0 percent], (f), and (g)(1)(iii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv) and (g)(2)(v), and (g)(5). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of SDSs does not apply when a SDS was not required under § 721.72(c) . The provisions of § 721.72(g) requiring placement of specific information on a label and SDS do not apply when a label and SDS are not required under § 721.72 (b) and (c) , respectively.(C)Industrial, commercial, and consumer activities. Requirements as specified in § 721.80(k) .(D)Disposal. Requirements as specified in § 721.85 (a)(1) and (a)(2), (b)(1) and (b)(2), and (c)(1) and (c)(2) .(ii)Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph.(A)Recordkeeping. The following recordkeeping requirements are applicable to manufacturers, importers, and processors of the substances, as specified in § 721.125 (a) through (k) .(B)Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this significant new use rule.(C)Determining whether a specific use is subject to this section. The provisions of § 721.1725(b)(1) apply to this section.(2) The chemical substance haloalkyl substituted cyclic ether (PMN P-85-367) is subject to reporting under this section for the significant new uses described in this paragraph. (i) The significant new uses are: (A)Protection in the workplace. Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), and (a)(6)(v) and (a)(6)(vi), (b) [concentration set at 0.1 percent], and (c).(B)Hazard communication program. Requirements as specified in § 721.72 (a), (d), (e) [concentration set at 0.1 percent], (f), and (g)(1)(iii), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv) and (g)(2)(v), and (g)(5). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of SDSs does not apply when a SDS was not required under § 721.72(c) . The provisions of § 721.72(g) requiring placement of specific information on a label and SDS do not apply when a label and SDS are not required under § 721.72 (b) and (c) , respectively.(C)Industrial, commercial, and consumer activities. Requirements as specified in § 721.80(k) .(D)Disposal. Requirements as specified in § 721.85 (a)(1), (a)(2), (b)(1) and (b)(2), and (c)(1) and (c)(2) .(ii)Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph.(A)Recordkeeping. The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (k) .(B)Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this significant new use rule.(C)Determining whether a specific use is subject to this section. The provisions of § 721.1725(b)(1) apply to this section.55 FR 26109, June 26, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993